Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Novel Biomarkers in Cardiac Resynchronization Therapy: Hepatocyte Growth Factor Is an Independent Predictor of Clinical Outcome.

Perge P, Boros AM, Szilágyi S, Zima E, Molnár L, Gellér L, Prohászka Z, Merkely B, Széplaki G.

Rev Esp Cardiol (Engl Ed). 2019 Jan;72(1):48-55. doi: 10.1016/j.rec.2017.12.015. Epub 2018 Mar 23. English, Spanish.

PMID:
29580749
2.

First experience with zero-fluoroscopic ablation for supraventricular tachycardias using a novel impedance and magnetic-field-based mapping system.

Walsh KA, Galvin J, Keaney J, Keelan E, Szeplaki G.

Clin Res Cardiol. 2018 Jul;107(7):578-585. doi: 10.1007/s00392-018-1220-8. Epub 2018 Feb 23.

3.

Evaluation of the Tp-Te Interval, QTc and P-Wave Dispersion in Patients With Coronary Artery Ectasia.

Conlon R, Tanner R, David S, Szeplaki G, Galvin J, Keaney J, Keelan E, Boles U.

Cardiol Res. 2017 Dec;8(6):280-285. doi: 10.14740/cr631w. Epub 2017 Dec 22.

4.

Automated ultra-high-density mapping of peri-sinus node premature atrial contractions.

Walsh KA, Galvin J, Keaney J, Keelan E, Szeplaki G.

Clin Res Cardiol. 2018 Apr;107(4):368-370. doi: 10.1007/s00392-017-1191-1. Epub 2017 Dec 8. No abstract available.

PMID:
29222593
5.

Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients.

Nagy KV, Széplaki G, Perge P, Boros AM, Kosztin A, Apor A, Molnár L, Szilágyi S, Tahin T, Zima E, Kutyifa V, Gellér L, Merkely B.

Europace. 2018 Sep 1;20(9):1506-1512. doi: 10.1093/europace/eux342.

6.

Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries.

Sticherling C, Arendacka B, Svendsen JH, Wijers S, Friede T, Stockinger J, Dommasch M, Merkely B, Willems R, Lubinski A, Scharfe M, Braunschweig F, Svetlosak M, Zürn CS, Huikuri H, Flevari P, Lund-Andersen C, Schaer BA, Tuinenburg AE, Bergau L, Schmidt G, Szeplaki G, Vandenberk B, Kowalczyk E, Eick C, Juntilla J, Conen D, Zabel M; EU-CERT-ICD Investigators.

Europace. 2018 Jun 1;20(6):963-970. doi: 10.1093/europace/eux176. Erratum in: Europace. 2018 Jun 1;20(6):970.

7.

The impact of cardiac resynchronization therapy on routine laboratory parameters.

Boros AM, Perge P, Nagy KV, Apor A, Bagyura Z, Zima E, Molnár L, Tahin T, Becker D, Gellér L, Merkely B, Széplaki G.

Interv Med Appl Sci. 2017 Mar;9(1):1-8. doi: 10.1556/1646.9.2017.1.01.

8.

Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent.

Bagyura Z, Kiss L, Hirschberg K, Berta B, Széplaki G, Lux Á, Szelid Z, Soós P, Merkely B.

Dis Markers. 2017;2017:9548612. doi: 10.1155/2017/9548612. Epub 2017 Mar 7.

9.

Isolation of the superior vena cava to block unidirectional exit conduction from the right-sided pulmonary veins during atrial fibrillation ablation.

Szeplaki G, Keaney J, Keelan E, Valentine J, Galvin J.

J Interv Card Electrophysiol. 2017 Aug;49(2):127-128. doi: 10.1007/s10840-017-0251-9. Epub 2017 Apr 8. No abstract available.

PMID:
28391548
10.

Minimal invasive right ventricular and atrial pacemaker lead repositioning as a first alternative is superior in avoiding pocket complications with passive fixation leads.

Osztheimer I, Szilágyi S, Pongor Z, Zima E, Molnár L, Tahin T, Özcan EE, Széplaki G, Merkely B, Gellér L.

J Interv Card Electrophysiol. 2017 Jun;49(1):33-38. doi: 10.1007/s10840-017-0242-x. Epub 2017 Mar 15.

PMID:
28299537
11.

High rate of in-stent restenosis after coronary intervention in carriers of the mutant mannose-binding lectin allele.

Bagyura Z, Kiss L, Berta B, Szilágyi Á, Hirschberg K, Széplaki G, Lux Á, Szelid Z, Soós P, Merkely B.

BMC Cardiovasc Disord. 2017 Jan 5;17(1):4. doi: 10.1186/s12872-016-0440-y.

12.

Complement C3a predicts outcome in cardiac resynchronization therapy of heart failure.

Széplaki G, Boros AM, Szilágyi S, Osztheimer I, Jenei Z, Kosztin A, Nagy KV, Karády J, Molnár L, Tahin T, Zima E, Gellér L, Prohászka Z, Merkely B.

Inflamm Res. 2016 Dec;65(12):933-940. Epub 2016 Aug 4.

PMID:
27492980
13.

Impact of CT-apelin and NT-proBNP on identifying non-responders to cardiac resynchronization therapy.

Kosztin A, Széplaki G, Kovács A, Földes G, Szokodi I, Vivien Nagy K, Kutyifa V, Fórizs É, Végh EM, Gellér L, Becker D, Aradi D, Merkely B.

Biomarkers. 2017 May - Jun;22(3-4):279-286. doi: 10.1080/1354750X.2016.1217931. Epub 2016 Aug 12.

14.

Isolation of persistent left superior vena cava during atrial fibrillation ablation.

Ozcan EE, Szeplaki G, Merkely B, Geller L.

Indian Pacing Electrophysiol J. 2015 Jul 29;15(2):130-2. doi: 10.1016/j.ipej.2015.07.011. eCollection 2015 Mar-Apr.

15.

Measurement of the Red Blood Cell Distribution Width Improves the Risk Prediction in Cardiac Resynchronization Therapy.

Boros AM, Perge P, Jenei Z, Karády J, Zima E, Molnár L, Becker D, Gellér L, Prohászka Z, Merkely B, Széplaki G.

Dis Markers. 2016;2016:7304538. doi: 10.1155/2016/7304538. Epub 2016 Jan 19.

16.

Respiratory gating algorithm helps to reconstruct more accurate electroanatomical maps during atrial fibrillation ablation performed under spontaneous respiration.

Széplaki G, Gellér L, Özcan EE, Tahin T, Kovács OM, Parázs N, Karády J, Maurovich-Horvat P, Szilágyi S, Osztheimer I, Tóth A, Merkely B.

J Interv Card Electrophysiol. 2016 Aug;46(2):153-9. doi: 10.1007/s10840-016-0105-x. Epub 2016 Jan 27.

PMID:
26814840
17.

[Successful direct thrombin inhibitor treatment of a left atrial appendage thrombus developed under rivaroxaban therapy].

Szegedi N, Gellér L, Tahin T, Merkely B, Széplaki G.

Orv Hetil. 2016 Jan 24;157(4):154-6. doi: 10.1556/650.2016.30350. Hungarian.

PMID:
26772828
18.

Role of Right Ventricular Global Longitudinal Strain in Predicting Early and Long-Term Mortality in Cardiac Resynchronization Therapy Patients.

Nagy VK, Széplaki G, Apor A, Kutyifa V, Kovács A, Kosztin A, Becker D, Boros AM, Gellér L, Merkely B.

PLoS One. 2015 Dec 23;10(12):e0143907. doi: 10.1371/journal.pone.0143907. eCollection 2015.

19.

Radiofrequency ablation of focal atrial tachycardia: Benefit of electroanatomical mapping over conventional mapping.

Szegedi N, Zima E, Clemens M, Szekely A, Kiss RG, Szeplaki G, Geller L, Merkely B, Csanadi Z, Duray G.

Acta Physiol Hung. 2015 Sep;102(3):252-62. doi: 10.1556/036.102.2015.3.3.

PMID:
26551741
20.

Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.

Kosztin A, Kutyifa V, Nagy VK, Geller L, Zima E, Molnar L, Szilagyi S, Ozcan EE, Szeplaki G, Merkely B.

Europace. 2016 Apr;18(4):550-9. doi: 10.1093/europace/euv117. Epub 2015 Jun 27.

Supplemental Content

Loading ...
Support Center